Tidal Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Tidal Investments's BMY Position: Q2 2026 in Review
Tidal Investments increased its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, buying an estimated $5.49M and bringing the position to 804,406 shares worth $46.3M. The position accounts for 0.08% of the portfolio, ranked #245.
Tidal Investments first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tidal Investments held 804,406 shares of Bristol-Myers Squibb worth $46.3M as of Q2 2026.
- Tidal Investments bought 95,689 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.49M.
- Bristol-Myers Squibb made up 0.08% of Tidal Investments's portfolio in Q2 2026, its #245 holding.
- Tidal Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.